Importer of Controlled Substances Registration: Research Triangle Institute, 4593 [2015-01578]

Download as PDF 4593 Federal Register / Vol. 80, No. 18 / Wednesday, January 28, 2015 / Notices Controlled substance Schedule 4-Anilino-N-phenethyl-4-piperidine (8333). Phenylacetone (8501) .................. Cocaine (9041) ............................. Opium, raw (9600) ....................... Poppy Straw Concentrate (9670) II II II II II The company plans to import the listed controlled substances for internal use, and to manufacture bulk intermediates for sale to its customers. Dated: January 21, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above-named company is granted registration as an importer of noroxymorphone (9668), a basic class of narcotic controlled substance listed in schedule II. The company plans to import small quantities of the listed controlled substance for the National Institute on Drug Abuse for research activities. Dated: January 21, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015–01578 Filed 1–27–15; 8:45 am] BILLING CODE 4410–09–P [FR Doc. 2015–01587 Filed 1–27–15; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–392] [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies Importer of Controlled Substances Registration: Research Triangle Institute ACTION: ACTION: Notice of registration. Research Triangle Institute applied to be registered as an importer of a certain basic class of narcotic controlled substance. The DEA grants Research Triangle Institute registration as an importer of this controlled substance. By notice dated April 21, 2014, and published in the Federal Register on April 28, 2014, 79 FR 23373, Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann Building, East Institute Drive, P.O. Box 12194, Research Triangle Park, North Carolina 27709, applied to be registered as an importer of a certain basic class of narcotic controlled substance. No comments or objections were submitted for this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of Research Triangle Institute to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. mstockstill on DSK4VPTVN1PROD with NOTICES VerDate Sep<11>2014 16:41 Jan 27, 2015 Jkt 235001 Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before March 30, 2015. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on March DATES: SUMMARY: SUPPLEMENTARY INFORMATION: Notice of application. PO 00000 Frm 00065 Fmt 4703 Sfmt 4703 13, 2014, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: Controlled substance Tetrahydrocannabinols (7370) ..... Methylphenidate (1724) ................ Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Levorphanol (9220) ...................... Morphine (9300) ........................... Oripavine (9330) ........................... Thebaine (9333) ........................... Oxymorphone (9652) ................... Noroxymorphone (9668) .............. Tapentadol (9780) ........................ Fentanyl (9801) ............................ Schedule I II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for conversion and sale to dosage form manufacturers. In reference to drug code 7370 the company plans to bulk manufacture a synthetic tetrahydrocannabinol. No other activity for this drug code is authorized for this registration. Dated: January 21, 2015. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2015–01598 Filed 1–27–15; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc. ACTION: Notice of registration. Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances. SUMMARY: By notice dated September 25, 2014, and published in the Federal Register on October 7, 2014, 79 FR 60498, Johnson Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, applied to be registered as a manufacturer of a certain basic class of controlled substance. No comments or objections were submitted to this notice. SUPPLEMENTARY INFORMATION: E:\FR\FM\28JAN1.SGM 28JAN1

Agencies

[Federal Register Volume 80, Number 18 (Wednesday, January 28, 2015)]
[Notices]
[Page 4593]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01578]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration: Research Triangle 
Institute

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Research Triangle Institute applied to be registered as an 
importer of a certain basic class of narcotic controlled substance. The 
DEA grants Research Triangle Institute registration as an importer of 
this controlled substance.

SUPPLEMENTARY INFORMATION: By notice dated April 21, 2014, and 
published in the Federal Register on April 28, 2014, 79 FR 23373, 
Research Triangle Institute, Kenneth S. Rehder, Ph.D., Hermann 
Building, East Institute Drive, P.O. Box 12194, Research Triangle Park, 
North Carolina 27709, applied to be registered as an importer of a 
certain basic class of narcotic controlled substance. No comments or 
objections were submitted for this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the 
registration of Research Triangle Institute to import the basic class 
of controlled substance is consistent with the public interest and with 
United States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated the company's 
maintenance of effective controls against diversion by inspecting and 
testing the company's physical security systems, verifying the 
company's compliance with state and local laws, and reviewing the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above-named company is granted 
registration as an importer of noroxymorphone (9668), a basic class of 
narcotic controlled substance listed in schedule II.
    The company plans to import small quantities of the listed 
controlled substance for the National Institute on Drug Abuse for 
research activities.

    Dated: January 21, 2015.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2015-01578 Filed 1-27-15; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.